Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Cash from Operations (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Cash from Operations for 5 consecutive years, with 11962000.0 as the latest value for Q4 2025.

  • For Q4 2025, Cash from Operations rose 28.9% year-over-year to 11962000.0; the TTM value through Dec 2025 reached 51777000.0, up 30.23%, while the annual FY2025 figure was 51777000.0, 30.23% up from the prior year.
  • Cash from Operations hit 11962000.0 in Q4 2025 for Kezar Life Sciences, down from 9830000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 8357000.0 in Q1 2021 and bottomed at 22862000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 15445850.0, with a median of 16121500.0 recorded in 2022.
  • Year-over-year, Cash from Operations plummeted 64.36% in 2022 and then surged 43.81% in 2025.
  • Kezar Life Sciences' Cash from Operations stood at 11081000.0 in 2021, then plummeted by 43.34% to 15883000.0 in 2022, then fell by 19.5% to 18980000.0 in 2023, then rose by 11.35% to 16825000.0 in 2024, then grew by 28.9% to 11962000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 11962000.0, 9830000.0, and 12795000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.